[Management of acute coronary syndrome : ESC guidelines 2023]

Maria Buske1, Hans-Josef Feistritzer1, Alexander Jobs1

  • 1Herzzentrum Leipzig - Universität Leipzig, Strümpellstr. 39, 04289, Leipzig, Deutschland.

Herz
|November 30, 2023
PubMed

Insights

The 2023 European Society of Cardiology guidelines update acute coronary syndrome (ACS) management for STEMI and NSTE-ACS. Key changes include invasive diagnostics timing, revascularization in multivessel disease, and bleeding risk-adapted antithrombotic therapy.

Area of Science:

  • Cardiology
  • Internal Medicine

Context:

  • The European Society of Cardiology (ESC) has released updated guidelines for managing acute coronary syndromes (ACS).
  • These 2023 guidelines consolidate and revise previous recommendations for ST-elevation myocardial infarction (STEMI) and non-ST-elevation ACS (NSTE-ACS).

Purpose:

  • To provide clinicians with the latest evidence-based recommendations for the diagnosis and management of ACS.
  • To outline updated strategies for acute and long-term treatment, including antithrombotic therapy and invasive procedures.

Summary:

  • The guidelines cover diagnostics, acute management, antithrombotic strategies, out-of-hospital cardiac arrest, cardiogenic shock, invasive interventions, and long-term care for ACS patients.
  • Significant updates include refined recommendations on the timing of invasive diagnostics for NSTE-ACS.
  • New guidance addresses revascularization in multivessel coronary artery disease and alternative antithrombotic regimens for high bleeding risk patients.

Impact:

  • These updated guidelines aim to optimize patient outcomes and standardize care for acute coronary syndromes across Europe.
  • The revisions facilitate improved clinical decision-making regarding invasive strategies and antithrombotic treatments, particularly in complex patient subsets.

Related Concept Videos

Cardiac Catheterization IV: Nursing Management01:26

Cardiac Catheterization IV: Nursing Management

Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
25
Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
126
Imaging Studies for Cardiovascular System I:Echocardiography01:17

Imaging Studies for Cardiovascular System I:Echocardiography

Cardiac imaging studies encompass a wide range of noninvasive and minimally invasive techniques designed to visualize the heart's structure and function in detail. One such technique is echocardiography, which uses high-frequency ultrasound waves to produce detailed images of the heart, known as echocardiograms.
Indications: Echocardiography is utilized to diagnose heart failure, valve disorders, and myocardial infarction. It also assesses cardiac structures' size, shape, and motion,...
337
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
533
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.5K
Guidelines and Strategies for Safe Computer Charting01:18

Guidelines and Strategies for Safe Computer Charting

The guidelines and strategies provided by the American Nurses Association (ANA) and the Canadian Nurses Association (CNA) offer essential principles for ensuring safe and secure computer charting systems in healthcare settings. Let's break down each recommendation:
Maintain Confidentiality and Security:
806